The overexpression of ATX has been found to stimulate tumour motility and invasiveness; increase metastatic potential, resistance to chemotherapy, and radiation-induced cell death; and translate into poor outcomes in cancer patients [222]. This evidence concerns the gene ENPP2 and neoplasm.